Scynexis (SCYX) EBITDA Margin (2013 - 2024)
Scynexis (SCYX) reported EBITDA Margin of -824.26% for Q4 2024, down 428.61 percentage points from -395.65% a year earlier but up 739.38 percentage points from the prior quarter.
Powered by 
Analysis
Scynexis (SCYX) EBITDA Margin (2013 - 2024) Analysis & Trends
For FY2024, Scynexis posted EBITDA Margin of -990.84%, down 1043.11 percentage points from FY2023.
- EBITDA Margin has a five-year change of +39348.00 percentage points (FY2019 to FY2024).
- By year, EBITDA Margin came in at 52.27% in FY2023 (+1724.85 pp), -1672.58% in FY2022 (-1213.27 pp) and -459.31% in FY2021.
- Five-year quarterly EBITDA Margin spans a low of -3758.33% in Q3 2021 and a high of 88.75% in Q2 2023.
- Year over year, EBITDA Margin has now declined in each of the last three quarters, with an average year-over-year change of +368.71 percentage points over the last eight quarters.
- The high point for year-over-year EBITDA Margin in five years was Q3 2022 (a gain of 2367.77 percentage points); the low point was Q1 2022 (a drop of 2784.57 percentage points).
- Per Business Quant data, the three quarters before Q4 2024 came in at -1563.64% (Q3 2024), -1255.03% (Q2 2024) and -692.50% (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 39.16% |
| 10 | Scynexis | 44.87 Mn | -26.23 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -776.77% |
| Sep 30, 2024 | -1,496.82% |
| Jun 30, 2024 | -1,197.83% |
| Mar 31, 2024 | -663.29% |
| Dec 31, 2023 | -389.13% |
| Sep 30, 2023 | -544.63% |
| Jun 30, 2023 | 90.27% |
| Mar 31, 2023 | -909.38% |
| Dec 31, 2022 | -1,439.04% |
| Sep 30, 2022 | -1,365.13% |
| Jun 30, 2022 | -1,600.23% |
| Mar 31, 2022 | -2,741.86% |
| Dec 31, 2021 | -3,632.33% |
| Sep 30, 2021 | -3,678.29% |
| Mar 31, 2021 | -10.88% |
| Jun 30, 2019 | -18,935.09% |
| Mar 31, 2019 | -18,175.00% |
| Dec 31, 2018 | -13,503.13% |
| Sep 30, 2018 | -9,659.38% |
| Jun 30, 2018 | -11,809.38% |
API Access
Scynexis EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SCYX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "SCYX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SCYX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();